Executives at CBL & Associates and Climb Bio execute stock sales

Stephen D. Lebovitz, CEO of CBL & Associates Properties, Inc., sold 50,000 shares of common stock on September 16. The transactions were executed at a weighted average price of $52.83 per share, totaling approximately $2.6 million.

Following the sale, Lebovitz maintains a substantial interest in the real estate investment trust, holding 507,019 directly held shares and 322 indirectly held shares, with a total post-transaction value of approximately $26.9 million.

In a separate transaction, Climb Bio, Inc. director Stephen Basil Thomas sold 100,000 shares on September 15 at an average price of $13.67, totaling $1,367,000. This sale represented a 17.61% decrease in his position, leaving him with 467,969 directly owned shares.